HEADER OXIDOREDUCTASE 24-OCT-18 6MV2 TITLE 2.05A RESOLUTION STRUCTURE OF THE CS-B5R DOMAINS OF HUMAN NCB5OR TITLE 2 (NADP+ FORM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME B5 REDUCTASE 4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CS-B5R DOMAINS (RESIDUES 164-521); COMPND 5 SYNONYM: FLAVOHEMOPROTEIN B5/B5R,B5+B5R,N-TERMINAL CYTOCHROME B5 AND COMPND 6 CYTOCHROME B5 OXIDOREDUCTASE DOMAIN-CONTAINING PROTEIN,CB5/CB5R; COMPND 7 EC: 1.6.2.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CYB5R4, NCB5OR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) PLYSS-RARE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET19B KEYWDS NCB5OR, ELECTRON TRANSFER, REDOX, HEME, ENDOPLASMIC RETICULUM, KEYWDS 2 FLAVOPROTEIN, IRON, METAL-BINDING, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR S.LOVELL,N.MEHZABEEN,K.P.BATTAILE,D.R.BENSON,A.COOPER,P.GAO,H.ZHU REVDAT 4 11-OCT-23 6MV2 1 REMARK REVDAT 3 01-JAN-20 6MV2 1 REMARK REVDAT 2 24-JUL-19 6MV2 1 JRNL REVDAT 1 17-JUL-19 6MV2 0 JRNL AUTH D.R.BENSON,S.LOVELL,N.MEHZABEEN,N.GALEVA,A.COOPER,P.GAO, JRNL AUTH 2 K.P.BATTAILE,H.ZHU JRNL TITL CRYSTAL STRUCTURES OF THE NATURALLY FUSED CS AND CYTOCHROME JRNL TITL 2 B5REDUCTASE (B5R) DOMAINS OF NCB5OR REVEAL AN EXPANDED CS JRNL TITL 3 FOLD, EXTENSIVE CS-B5R INTERACTIONS AND PRODUCTIVE BINDING JRNL TITL 4 OF THE NAD(P)+NICOTINAMIDE RING. JRNL REF ACTA CRYSTALLOGR D STRUCT V. 75 628 2019 JRNL REF 2 BIOL JRNL REFN ISSN 2059-7983 JRNL PMID 31282472 JRNL DOI 10.1107/S205979831900754X REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 27439 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1370 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.3420 - 4.4144 1.00 2677 128 0.1550 0.1759 REMARK 3 2 4.4144 - 3.5048 1.00 2627 137 0.1416 0.1975 REMARK 3 3 3.5048 - 3.0620 1.00 2578 158 0.1748 0.2227 REMARK 3 4 3.0620 - 2.7822 1.00 2592 153 0.1846 0.2469 REMARK 3 5 2.7822 - 2.5828 1.00 2611 133 0.1849 0.2550 REMARK 3 6 2.5828 - 2.4306 1.00 2573 155 0.1912 0.2626 REMARK 3 7 2.4306 - 2.3089 1.00 2618 113 0.1924 0.2415 REMARK 3 8 2.3089 - 2.2084 1.00 2579 146 0.2079 0.2669 REMARK 3 9 2.2084 - 2.1234 1.00 2591 145 0.2232 0.3181 REMARK 3 10 2.1234 - 2.0501 1.00 2623 102 0.2434 0.2554 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.800 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2958 REMARK 3 ANGLE : 1.100 4053 REMARK 3 CHIRALITY : 0.062 471 REMARK 3 PLANARITY : 0.006 494 REMARK 3 DIHEDRAL : 13.500 1734 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6MV2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1000237651. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-NOV-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.29 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27467 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 43.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.60100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.17 REMARK 200 STARTING MODEL: 2EIX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% (W/V) PEG 6000, 0.1 M HEPES, 0.3 M REMARK 280 NDSB-195, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.42100 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 155 REMARK 465 GLY A 156 REMARK 465 HIS A 157 REMARK 465 HIS A 158 REMARK 465 HIS A 159 REMARK 465 HIS A 160 REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 465 MET A 163 REMARK 465 GLY A 164 REMARK 465 PRO A 165 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 188 CG CD CE NZ REMARK 470 GLN A 200 CD OE1 NE2 REMARK 470 GLU A 207 CD OE1 OE2 REMARK 470 LYS A 211 CD CE NZ REMARK 470 GLN A 226 CD OE1 NE2 REMARK 470 ARG A 232 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 248 CD OE1 OE2 REMARK 470 LYS A 260 CD CE NZ REMARK 470 ARG A 268 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 269 CG CD CE NZ REMARK 470 GLU A 336 CD OE1 OE2 REMARK 470 ARG A 366 CZ NH1 NH2 REMARK 470 LYS A 383 CG CD CE NZ REMARK 470 LYS A 386 CD CE NZ REMARK 470 ARG A 420 CD NE CZ NH1 NH2 REMARK 470 LYS A 423 CE NZ REMARK 470 LYS A 446 CD CE NZ REMARK 470 LYS A 448 CG CD CE NZ REMARK 470 ILE A 460 CG1 CG2 CD1 REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 ASN A 464 CG OD1 ND2 REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 LYS A 480 CD CE NZ REMARK 470 ARG A 481 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 482 CG OD1 ND2 REMARK 470 GLN A 501 CD OE1 NE2 REMARK 470 ARG A 504 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 513 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 800 O HOH A 820 1.96 REMARK 500 O HOH A 810 O HOH A 856 1.99 REMARK 500 O HOH A 839 O HOH A 915 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 175 -165.19 -112.10 REMARK 500 ASP A 189 8.94 80.96 REMARK 500 LYS A 211 -122.24 60.59 REMARK 500 LEU A 259 -168.88 -117.03 REMARK 500 ALA A 458 54.70 -151.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FAD A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 602 DBREF 6MV2 A 164 521 UNP Q7L1T6 NB5R4_HUMAN 164 521 SEQADV 6MV2 MET A 155 UNP Q7L1T6 INITIATING METHIONINE SEQADV 6MV2 GLY A 156 UNP Q7L1T6 EXPRESSION TAG SEQADV 6MV2 HIS A 157 UNP Q7L1T6 EXPRESSION TAG SEQADV 6MV2 HIS A 158 UNP Q7L1T6 EXPRESSION TAG SEQADV 6MV2 HIS A 159 UNP Q7L1T6 EXPRESSION TAG SEQADV 6MV2 HIS A 160 UNP Q7L1T6 EXPRESSION TAG SEQADV 6MV2 HIS A 161 UNP Q7L1T6 EXPRESSION TAG SEQADV 6MV2 HIS A 162 UNP Q7L1T6 EXPRESSION TAG SEQADV 6MV2 MET A 163 UNP Q7L1T6 EXPRESSION TAG SEQRES 1 A 367 MET GLY HIS HIS HIS HIS HIS HIS MET GLY PRO SER TYR SEQRES 2 A 367 PRO SER TYR ASP TRP PHE GLN THR ASP SER LEU VAL THR SEQRES 3 A 367 ILE ALA ILE TYR THR LYS GLN LYS ASP ILE ASN LEU ASP SEQRES 4 A 367 SER ILE ILE VAL ASP HIS GLN ASN ASP SER PHE ARG ALA SEQRES 5 A 367 GLU THR ILE ILE LYS ASP CYS LEU TYR LEU ILE HIS ILE SEQRES 6 A 367 GLY LEU SER HIS GLU VAL GLN GLU ASP PHE SER VAL ARG SEQRES 7 A 367 VAL VAL GLU SER VAL GLY LYS ILE GLU ILE VAL LEU GLN SEQRES 8 A 367 LYS LYS GLU ASN THR SER TRP ASP PHE LEU GLY HIS PRO SEQRES 9 A 367 LEU LYS ASN HIS ASN SER LEU ILE PRO ARG LYS ASP THR SEQRES 10 A 367 GLY LEU TYR TYR ARG LYS CYS GLN LEU ILE SER LYS GLU SEQRES 11 A 367 ASP VAL THR HIS ASP THR ARG LEU PHE CYS LEU MET LEU SEQRES 12 A 367 PRO PRO SER THR HIS LEU GLN VAL PRO ILE GLY GLN HIS SEQRES 13 A 367 VAL TYR LEU LYS LEU PRO ILE THR GLY THR GLU ILE VAL SEQRES 14 A 367 LYS PRO TYR THR PRO VAL SER GLY SER LEU LEU SER GLU SEQRES 15 A 367 PHE LYS GLU PRO VAL LEU PRO ASN ASN LYS TYR ILE TYR SEQRES 16 A 367 PHE LEU ILE LYS ILE TYR PRO THR GLY LEU PHE THR PRO SEQRES 17 A 367 GLU LEU ASP ARG LEU GLN ILE GLY ASP PHE VAL SER VAL SEQRES 18 A 367 SER SER PRO GLU GLY ASN PHE LYS ILE SER LYS PHE GLN SEQRES 19 A 367 GLU LEU GLU ASP LEU PHE LEU LEU ALA ALA GLY THR GLY SEQRES 20 A 367 PHE THR PRO MET VAL LYS ILE LEU ASN TYR ALA LEU THR SEQRES 21 A 367 ASP ILE PRO SER LEU ARG LYS VAL LYS LEU MET PHE PHE SEQRES 22 A 367 ASN LYS THR GLU ASP ASP ILE ILE TRP ARG SER GLN LEU SEQRES 23 A 367 GLU LYS LEU ALA PHE LYS ASP LYS ARG LEU ASP VAL GLU SEQRES 24 A 367 PHE VAL LEU SER ALA PRO ILE SER GLU TRP ASN GLY LYS SEQRES 25 A 367 GLN GLY HIS ILE SER PRO ALA LEU LEU SER GLU PHE LEU SEQRES 26 A 367 LYS ARG ASN LEU ASP LYS SER LYS VAL LEU VAL CYS ILE SEQRES 27 A 367 CYS GLY PRO VAL PRO PHE THR GLU GLN GLY VAL ARG LEU SEQRES 28 A 367 LEU HIS ASP LEU ASN PHE SER LYS ASN GLU ILE HIS SER SEQRES 29 A 367 PHE THR ALA HET FAD A 601 53 HET NAP A 602 48 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 FAD C27 H33 N9 O15 P2 FORMUL 3 NAP C21 H28 N7 O17 P3 FORMUL 4 HOH *221(H2 O) HELIX 1 AA1 LYS A 269 THR A 271 5 3 HELIX 2 AA2 LEU A 359 LEU A 367 1 9 HELIX 3 AA3 LYS A 383 GLN A 388 5 6 HELIX 4 AA4 PHE A 402 ASP A 415 1 14 HELIX 5 AA5 THR A 430 ILE A 434 5 5 HELIX 6 AA6 TRP A 436 LYS A 446 1 11 HELIX 7 AA7 SER A 471 LEU A 479 1 9 HELIX 8 AA8 PRO A 495 LEU A 509 1 15 HELIX 9 AA9 SER A 512 ASN A 514 5 3 SHEET 1 AA1 4 SER A 169 GLN A 174 0 SHEET 2 AA1 4 LEU A 178 TYR A 184 -1 O THR A 180 N PHE A 173 SHEET 3 AA1 4 LYS A 239 GLN A 245 -1 O LEU A 244 N VAL A 179 SHEET 4 AA1 4 SER A 230 VAL A 234 -1 N VAL A 234 O LYS A 239 SHEET 1 AA2 3 GLY A 256 PRO A 258 0 SHEET 2 AA2 3 CYS A 213 LEU A 221 -1 N GLY A 220 O HIS A 257 SHEET 3 AA2 3 SER A 264 PRO A 267 -1 O ILE A 266 N LEU A 214 SHEET 1 AA3 5 GLY A 256 PRO A 258 0 SHEET 2 AA3 5 CYS A 213 LEU A 221 -1 N GLY A 220 O HIS A 257 SHEET 3 AA3 5 SER A 203 ILE A 210 -1 N ALA A 206 O ILE A 217 SHEET 4 AA3 5 ILE A 195 HIS A 199 -1 N ASP A 198 O ARG A 205 SHEET 5 AA3 5 THR A 301 HIS A 302 -1 O HIS A 302 N VAL A 197 SHEET 1 AA4 6 THR A 320 TYR A 326 0 SHEET 2 AA4 6 VAL A 311 ILE A 317 -1 N LEU A 315 O ILE A 322 SHEET 3 AA4 6 PHE A 372 SER A 376 -1 O SER A 376 N TYR A 312 SHEET 4 AA4 6 TYR A 275 ASP A 285 -1 N ARG A 276 O VAL A 375 SHEET 5 AA4 6 THR A 290 MET A 296 -1 O LEU A 292 N GLU A 284 SHEET 6 AA4 6 TYR A 347 LYS A 353 -1 O ILE A 348 N LEU A 295 SHEET 1 AA5 6 LYS A 466 GLN A 467 0 SHEET 2 AA5 6 LEU A 450 LEU A 456 1 N LEU A 456 O LYS A 466 SHEET 3 AA5 6 LYS A 421 ASN A 428 1 N LEU A 424 O ASP A 451 SHEET 4 AA5 6 ASP A 392 ALA A 398 1 N ALA A 397 O PHE A 427 SHEET 5 AA5 6 VAL A 488 CYS A 493 1 O LEU A 489 N PHE A 394 SHEET 6 AA5 6 ILE A 516 PHE A 519 1 O HIS A 517 N VAL A 490 SITE 1 AC1 24 HIS A 310 LYS A 324 PRO A 325 TYR A 326 SITE 2 AC1 24 THR A 327 LEU A 351 ILE A 352 LYS A 353 SITE 3 AC1 24 THR A 357 GLY A 358 LEU A 359 PHE A 360 SITE 4 AC1 24 THR A 361 THR A 400 THR A 403 NAP A 602 SITE 5 AC1 24 HOH A 736 HOH A 742 HOH A 759 HOH A 782 SITE 6 AC1 24 HOH A 792 HOH A 846 HOH A 852 HOH A 857 SITE 1 AC2 25 LYS A 353 TYR A 355 ALA A 398 GLY A 399 SITE 2 AC2 25 THR A 400 GLY A 401 THR A 403 ASN A 428 SITE 3 AC2 25 LYS A 429 SER A 457 HIS A 469 CYS A 493 SITE 4 AC2 25 GLY A 494 PRO A 495 PRO A 497 PHE A 519 SITE 5 AC2 25 THR A 520 FAD A 601 HOH A 727 HOH A 729 SITE 6 AC2 25 HOH A 752 HOH A 809 HOH A 829 HOH A 834 SITE 7 AC2 25 HOH A 852 CRYST1 56.265 68.842 57.630 90.00 97.43 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017773 0.000000 0.002317 0.00000 SCALE2 0.000000 0.014526 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017499 0.00000